Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100μg/50μg)
Not Applicable
Completed
- Conditions
- Asthma
- Interventions
- First Posted Date
- 2018-05-24
- Last Posted Date
- 2019-11-29
- Lead Sponsor
- West-Ward Pharmaceutical
- Target Recruit Count
- 1556
- Registration Number
- NCT03535870
- Locations
- 🇺🇸
West-Ward Research Site #1, Las Vegas, Nevada, United States
Study of Oral Morphine Sulfate Administration in Pediatric Subjects
- First Posted Date
- 2018-02-12
- Last Posted Date
- 2019-09-26
- Lead Sponsor
- West-Ward Pharmaceutical
- Target Recruit Count
- 51
- Registration Number
- NCT03429400
- Locations
- 🇺🇸
Site 105, Sheffield, Alabama, United States
Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV
- First Posted Date
- 2014-12-23
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- West-Ward Pharmaceutical
- Target Recruit Count
- 100
- Registration Number
- NCT02323399
- Locations
- 🇺🇸
Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia, United States
🇺🇸Children's Medical Center of Dallas, Dallas, Texas, United States
🇺🇸Stony Brook Medicine, Stony Brook, New York, United States
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
- First Posted Date
- 2011-01-27
- Last Posted Date
- 2017-11-14
- Lead Sponsor
- West-Ward Pharmaceutical
- Target Recruit Count
- 314
- Registration Number
- NCT01284556
- Locations
- 🇵🇷
Centro Neurodiagnostico, Rio Piedras, Puerto Rico
🇵🇷Hospital Del Maestro, San Juan, Puerto Rico
🇺🇸Bluegrass Epilepsy Research, Lexington, Kentucky, United States
© Copyright 2025. All Rights Reserved by MedPath